Palisade Bio shares are trading higher after Ladenburg Thalmann initiated coverage on the stock with a Buy rating and announced a $5 price target.
https://www.benzinga.com/wiim/22/02/25367808/palisade-bio-shares-are-trading-higher-after-ladenburg-thalmann-initiated-coverage-on-the-stock-with https://www.benzinga.com/wiim/22/02/25367808/palisade-bio-shares-are-trading-higher-after-ladenburg-thalmann-initiated-coverage-on-the-stock-with